Jordan A. Haber

Jordan A. Haber

Auto-generated profile, based on publicly available information

Jordan A. Haber

Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2024 in Seminars in Arthroplasty: JSES
Verified
Journal Article
Open access
ASAndrew J. Stevens
Andrew J. Stevens
AIAmogh I. Iyer
Amogh I. Iyer
GBGalo C. Bustamante
Galo C. Bustamante
JHJordan Haber
Jordan Haber
APAkshar V. Patel
Akshar V. Patel
RRRyan C. Rauck
Ryan C. Rauck

18 May 2024 in Seminars in Arthroplasty: JSES
Verified
Journal Article
Open access
EKErryk S. Katayama
Erryk S. Katayama
LBLouis W. Barry
Louis W. Barry
GDGeorge R. Durisek
George R. Durisek
JHJordan Haber
Jordan Haber
JBJohn S. Barnett
John S. Barnett
RRRyan C. Rauck
Ryan C. Rauck

5 May 2024 in Seminars in Arthroplasty: JSES
Verified
Journal Article
Open access
JHJordan A. Haber
Jordan A. Haber
AIAmogh I. Iyer
Amogh I. Iyer
ASAndrew J. Stevens
Andrew J. Stevens
LBLouis Barry
Louis Barry
EKErryk Katayama
Erryk Katayama
RRRyan C. Rauck
Ryan C. Rauck

12 April 2024 in Seminars in Arthroplasty: JSES
Verified
Journal Article
Open access
SWSeth B. Wilson
Seth B. Wilson
ASAndrew J. Stevens
Andrew J. Stevens
JHJordan A. Haber
Jordan A. Haber
EKErryk Katayama
Erryk Katayama
LBLouis Barry
Louis Barry
RRRyan C. Rauck
Ryan C. Rauck

19 July 2024 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Open access
APAkshar V. Patel
Akshar V. Patel
GDGeorge R. Durisek
George R. Durisek
EKErryk S. Katayama
Erryk S. Katayama
AIAmogh I. Iyer
Amogh I. Iyer
JHJordan Haber
Jordan Haber
RRRyan C. Rauck
Ryan C. Rauck
Solid organ transplant (SOT) recipients are commonly prescribed immunosuppressive therapies which may predispose patients to higher infection and complication rates following total shoulder arthroplasty. This article aims to analyze the effects SOT and subsequent immunosuppressive regimens have on the functional and patient-reported outcomes of total shoulder arthroplasties. A single institution, multisurgeon retrospective case-control study investigating the functional and patient-reported outcomes of shoulder arthroplasty after SOT was conducted between the years of 2010 and 2020. To be included in the study, patients must have undergone SOT prior to primary total shoulder arthroplasty. A 4:1 match-paired control group lacking SOT prior to arthroplasty was then constructed. Thirty-four SOT patients (18 males and 16 females) and 136 control patients (77 male and 59 female) were included in the study. Patients were analyzed who underwent SOT prior to shoulder arthroplasty, with outcomes compared to controls that only underwent arthroplasty. The primary outcomes include range of motion and strength in forward elevation, external rotation, and internal rotation, and patient reported outcomes. There was no significant difference in improvement for range of motion and strength between the 2 cohorts, but within each cohort, improvement was statistically significant. In the SOT patients, forward elevation improved by 56° ± 52°, external rotation increased by 13° ± 20°, and internal rotation increased by 2 vertebral levels. In the non-SOT patients, forward elevation improved by 45° ± 51°, external rotation increased by 16° ± 25°, and internal rotation increased by 3 vertebral levels. SOT patients had equivocal visual analog scale pain and Simple Shoulder Test scores but lower American Shoulder and Elbow Surgeons (59 ± 13 vs. 79 ± 2; P = .002) and SANE (61 ± 30 vs. 84 ± 17; P < .001) scores than non-SOT patients. Complication rates were not significantly higher in the SOT group (15% vs. 6%; P = .05), but incidence of surgical revisions was not significantly different (SOT = 3%; non-SOT = 5%; P = .59). Shoulder arthroplasty is a safe, effective surgical intervention for improving shoulder function in patients with a history of SOT. Despite being on chronic immunosuppressive regimens, our solid organ transplants had comparable clinical outcomes and revision rates, but higher complication rates.

1 January 2025 in Advances in Orthopedics
Verified
Journal Article
Open access
JHJordan A. Haber
Jordan A. Haber
AIAmogh I. Iyer
Amogh I. Iyer
MDMatthew Dulas
Matthew Dulas
DWDouglas Weaver
Douglas Weaver
JSJason Strelzow
Jason Strelzow
Intramedullary nail fixation is the “gold standard” for surgical intervention of femoral fractures. While many aspects of nail design and patient anatomy have received specific focus, anatomic variations in proximal femoral geometry and greater trochanteric height variation have been poorly studied. Understanding the potential relationship of the greater trochanter to patient demographics may provide an opportunity to improve implant placement. Retrospective review of x‐ray and computed tomography images of the proximal femur was performed. Inclusion criteria consisted of skeletally mature patients over 18 years old with imaging of the proximal femur. Inclusion criteria identified 296 patients. Mean age of included patients was 34 ± 20 years. Average greater trochanter height was 40 ± 8.1 mm. Mean caput‐collum‐diaphyseal angle was 141 ± 8.6 degrees. After identifying significant factors using univariate analyses a multivariable linear regression demonstrated that patient height and caput‐collum‐diaphyseal angle were statistically significant predictors for greater trochanter height. For every 1 cm increase in patient height there was a predicted 0.11 mm increase in greater trochanter height ( p = 0.01). Conversely, every 1 degree increase in caput‐collum‐diaphyseal angle results in an associated 0.17 mm decrease in greater trochanter height ( p < 0.001). This study provides information that may allow for the potential optimization of implant design or implant position to minimize proximal nail protrusion, enhance nail fit and ensure cephalomedullary lag screw position in the head based on the proximal nail dimensions of the implant used.